# Relmada Therapeutics, Inc.: Form 8-K, filed Nov 12, 2015

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2015-11-12
- Accepted by EDGAR: Nov 12, 2015, 16:41 ET
- Period: 2015-11-06
- Accession: 0001213900-15-008498
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390015008498/f8k110615_relmadatherap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390015008498/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390015008498/f8k110615_relmadatherap.htm

Filed Nov 12, 2015.
Source: SEC EDGAR, the filing index for accession 0001213900-15-008498. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
